<div class="container">

<table style="width: 100%;"><tr>
<td>IBCSG_hist</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>International Breast Cancer Study Group (IBCSG) Trial VI Data</h2>

<h3>Description</h3>

<p>A data set from the IBCSG Trial VI investigating both the duration of adjuvant chemotherapy
(3 versus 6 initial cycles of oral cyclophosphamide, methotrexate, and fluorouracil (CMF)) and
the reintroduction of single courses of delayed chemotherapy in node-positive premenopausal
breast cancer patients. The study results were described by IBCSG (1996) <a href="doi:10.1200/JCO.1996.14.6.1885">doi:10.1200/JCO.1996.14.6.1885</a>
and Hürny et al. (1992) <a href="doi:10.1016/0959-8049(92)90399-m">doi:10.1016/0959-8049(92)90399-m</a>. This data set only includes patients
under the age of 40 (i.e., age &lt; 40) and treats the measurements of patients' physical well-being
on month 18 as the outcome. The IBCSG_curr data set includes patients from the same study but
with age <code class="reqn">\geq</code> 40. We can use the IBCSG_hist data as the historical data and the IBCSG_curr data as
the current data.
</p>


<h3>Usage</h3>

<pre><code class="language-R">IBCSG_hist
</code></pre>


<h3>Format</h3>

<p>A data frame with 103 rows and 8 variables:
</p>

<dl>
<dt>phys18</dt>
<dd>
<p>outcome variable, integer scores between 0 and 100 measuring
the patients' physical well-being on month 18, with a higher
score indicating a better physical well-being</p>
</dd>
<dt>phys1</dt>
<dd>
<p>physical well-being scores assessed at the start of the study</p>
</dd>
<dt>n_init_cycles</dt>
<dd>
<p>number of initial cycles of CMF, equal to 3 or 6</p>
</dd>
<dt>reintroduction</dt>
<dd>
<p>indicator of reintroduction of chemotherapy, 0 = no
reintroduction, 1 = having reintroduction</p>
</dd>
<dt>age</dt>
<dd>
<p>patient age in years</p>
</dd>
<dt>country</dt>
<dd>
<p>country, ANZ = New Zealand/Australia, CH = Switzerland,
SWED = Sweden</p>
</dd>
<dt>nodegp</dt>
<dd>
<p>indicator of number of positive nodes being greater than or
equal to 4, 0 = less than 4, 1 = 4+</p>
</dd>
<dt>ER</dt>
<dd>
<p>estrogen receptor (ER) status indicator, 0 = negative, 1 = positive</p>
</dd>
</dl>
<h3>References</h3>

<p>International Breast Cancer Study Group. (1996). Duration and reintroduction of adjuvant chemotherapy for node-positive premenopausal breast cancer patients. Journal of Clinical Oncology, 14(6), 1885–1894.
</p>
<p>Hürny, C., Bernhard, J., Gelber, R. D., Coates, A., Castiglione, M., Isley, M., Dreher, D., Peterson, H., Goldhirsch, A., and Senn, H.-J. (1992). Quality of life measures for patients receiving adjuvant therapy for breast cancer: An international trial. European Journal of Cancer, 28(1), 118–124.
</p>
<p>Chi, Y.-Y. and Ibrahim, J. G. (2005). Joint models for multivariate longitudinal and Multivariate Survival Data. Biometrics, 62(2), 432–445.
</p>


</div>